Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins

scientific article published on April 1, 1991

Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0090-8258(91)90255-4
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0090825891902554?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0090825891902554?httpAccept=text/xml
P698PubMed publication ID1851126

P2093author name stringC. Cavallo
D. Meehan
J. Wimalasena
P2860cites workElevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndromeQ70359483
Functioning ovarian tumors in postmenopausal womenQ70772992
Investigation of Binding Sites for Follicle-Stimulating Hormone and Chorionic Gonadotropin in Human Ovarian Cancers*Q72386176
Multiple biochemical markers in patients with gynecologic malignanciesQ72640920
An immunohistochemical study of the incidence and significance of human chorionic gonadotrophin synthesis by epithelial ovarian neoplasmsQ72709062
Steroid synthesis in cystadenocarcinoma of the ovariesQ72752693
Steroid receptors and response of ovarian cancer to hormones in vitroQ72814566
Gonadotropic hormone binding to human ovarian tumorsQ72912095
LH(hCG) Receptor in Benign and Malignant Tumors of Human OvaryQ72913615
Some observations on the effect of a GnRH analog in ovarian cancerQ93519708
A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidQ26778512
Determinants of ovarian cancer risk. II. Inferences regarding pathogenesisQ34055956
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerQ34254918
An immunohistochemical study of the incidence and significance of human gonadotrophin and prolactin binding sites in normal and neoplastic human ovarian tissueQ36027003
Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinomaQ41251384
CA-125 serum concentrations during the menstrual cycleQ41879833
Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cellsQ42813086
Human chorionic gonadotropin, follicle-stimulating hormone, and luteinizing hormone in patients with epithelial ovarian carcinomaQ44026933
Androstenedione production by malignant epithelial ovarian tumors.Q51802553
Plasma progesterone and androstenedione in relation to changes in tumor volume and recurrence in women with ovarian carcinoma.Q51815715
Plasma 20 alpha-OH-progesterone in women with malignant epithelial 'non-endocrine' ovarian tumors.Q51832174
Progesterone as a possible tumor marker for "nonendocrine" ovarian malignant tumors.Q51852197
Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinomaQ67949611
Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancerQ68519063
Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancerQ68827020
Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancerQ69172854
Localization of gonadotropin binding sites in human ovarian neoplasmsQ69357943
Androgen and estrogen secretion by normal and neoplastic ovaries in premenopausal womenQ69577255
Correlation of aromatase activity and steroid receptors in human ovarian carcinomaQ70159973
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectoncologyQ162555
ovarian cancerQ172341
P304page(s)56-63
P577publication date1991-04-01
P1433published inGynecologic OncologyQ5625182
P1476titleHuman epithelial ovarian cancer cell steroid secretion and its control by gonadotropins
P478volume41

Reverse relations

cites work (P2860)
Q92344331Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms
Q40690543Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today?
Q41457706Estrogen action in human ovarian cancer
Q36790475Gonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium.
Q35683646Growth regulation of ovarian cancer.
Q71031979HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells
Q33541940Hormonal interactions in ovarian cancer
Q35068355Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone
Q73932015Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma
Q28371622Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
Q57267084Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways
Q40869257The biology of ovarian cancer development.
Q71816408The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and α-subunit in vitro